Health Sciences Gr Stock Probability of Future Pink Sheet Price Finishing Under 0.0
Health Sciences' future price is the expected price of Health Sciences instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Health Sciences Gr performance during a given time horizon utilizing its historical volatility. Check out Health Sciences Backtesting, Health Sciences Valuation, Health Sciences Correlation, Health Sciences Hype Analysis, Health Sciences Volatility, Health Sciences History as well as Health Sciences Performance.
Please specify Health Sciences' target price for which you would like Health Sciences odds to be computed.
Health |
Health Sciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Health Sciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Health Sciences Gr can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Health Sciences Gr generated a negative expected return over the last 90 days | |
| Health Sciences Gr has some characteristics of a very speculative penny stock | |
| Health Sciences Gr has high likelihood to experience some financial distress in the next 2 years | |
| Health Sciences Gr currently holds 407 K in liabilities. Health Sciences Gr has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Health Sciences until it has trouble settling it off, either with new capital or with free cash flow. So, Health Sciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Health Sciences Gr sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Health to invest in growth at high rates of return. When we think about Health Sciences' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 358.43 K. Net Loss for the year was (54.49 K) with profit before overhead, payroll, taxes, and interest of 22.91 K. |
Health Sciences Technical Analysis
Health Sciences' future price can be derived by breaking down and analyzing its technical indicators over time. Health Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Health Sciences Gr. In general, you should focus on analyzing Health Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Health Sciences Predictive Forecast Models
Health Sciences' time-series forecasting models is one of many Health Sciences' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Health Sciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Health Sciences Gr
Checking the ongoing alerts about Health Sciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Health Sciences Gr help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Health Sciences Gr generated a negative expected return over the last 90 days | |
| Health Sciences Gr has some characteristics of a very speculative penny stock | |
| Health Sciences Gr has high likelihood to experience some financial distress in the next 2 years | |
| Health Sciences Gr currently holds 407 K in liabilities. Health Sciences Gr has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Health Sciences until it has trouble settling it off, either with new capital or with free cash flow. So, Health Sciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Health Sciences Gr sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Health to invest in growth at high rates of return. When we think about Health Sciences' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 358.43 K. Net Loss for the year was (54.49 K) with profit before overhead, payroll, taxes, and interest of 22.91 K. |
Other Information on Investing in Health Pink Sheet
Health Sciences financial ratios help investors to determine whether Health Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Health with respect to the benefits of owning Health Sciences security.